GlassScriptPhysician profile
Angela M Dawson
NPI 1467588160
$1,288.05
in general payments reported to CMS, 2019-2025
21 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $167 · 2022: $226 · 2023: $272 · 2024: $209 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.29 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $233.39 | 2022-2024 | Nexplanon |
| Astellas Pharma US INC | $182.14 | 2019-2023 | Veozah |
| Abbvie INC. | $160.55 | 2020-2025 | |
| Pfizer INC. | $113.13 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.80 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $86.24 | 2023-2025 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $82.95 | 2019-2020 | |
| Gilead Sciences, INC. | $51.36 | 2022 | |
| Coopersurgical, INC. | $42.67 | 2019-2022 | |
| Allergan, INC. | $35.44 | 2019 | |
| Hologic Sales and Service, LLC | $35.00 | 2025 | Novasure, Myosure Tissue Removal Device |
| Boston Scientific Corporation | $31.77 | 2023-2025 | Bulkamid, Solyx Sis System |
| Daiichi Sankyo INC. | $26.59 | 2024 | Injectafer |
| Axonics, INC. | $18.62 | 2024 | Bulkamid, Axonics |
| Novo Nordisk INC | $16.07 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.58 | 2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $14.97 | 2022 | |
| Agile Therapeutics, INC. | $13.84 | 2022 | |
| Exeltis, USA INC. | $13.71 | 2024 | Slynd |
| Amgen INC. | $13.23 | 2023 | Prolia, Evenity |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.